were assigned using MarvinSketch 6.1.5. A solution of 2 (0.775 g, 1.7 mmol) in 8 mL of THF was cooled to 0°C, and a solution of trichloroacetic acid (5.56 g, 34 mmol) in 10 mL of H2O was added. The reaction mixture was stirred for 1 h at 0°C. R eaction progress was monitored by TLC (EtOAc:Hexanes = 2:1).
II. Chemical Synthesis
After 1 h the reaction mixture was quenched with solid Na2CO3, and 20 mL of water was added. The product was extracted with CH2Cl2 (3×10 mL). The combined organic layers were washed with brine and dried over Na2SO4. After filtration, the solvent was removed, and the residue was purified by silica gel column chromatography (EtOAc:Hexanes, 1:1 → 
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Alcohol 3 (120 mg, 0.35 mmol) was dissolved in 4 mL of CH3CN, and freshly prepared IBX (108 mg, 0.385 mmol) was added. The reaction mixture was refluxed for 1 h. Product formation was monitored by TLC (EtOAc:Hexanes = 2:1). Upon completion of the reaction, the mixture was cooled to 0°C, filtered and washed with cold acetonitrile. The solvent was removed, and the residue was co-evaporated with dry THF and then dried under high vacuum. Aldehyde 4 was used in the following reaction without further purification.
To a suspension of NaH (26 mg, 0.65 mmol) in dry THF (2 mL) at 0°C was added a solution of tetramethyl methylenebisphosphonate in 4 mL of dry THF. The reaction mixture was stirred at 0°C for 10 min. The resulting suspension was then added dropwise to a solution of aldehyde 4 in 4 mL of dry THF at 0°C. The reaction mixture was stirred for 3 h and allowed to slowly warm up to rt. It was then quenched with saturated NH4Cl and extracted with EtOAc (3×10 mL). The combined organic layers were washed with brine and dried over Na2SO4. The residue was purified by silica gel column chromatography (1% MeOH in EtOAc), giving 124 mg of 5 as a colorless oil (79% over two steps). 31 Compound 6 (17 mg, 0.038 mmol) was dissolved in 500 µL of dry acetonitrile, and BTMS (bromotrimethylsilane; 11 µL, 0.08 mmol) was added. The reaction mixture was microwaved at 60°C for 7 min. Volatiles were removed under reduced pressure, and the residue treated with water. After stirring for 30 min, water was evaporated, the reaction mixture dried under vacuum and the resulting residue used in the following step without further purification.
A sample of compound 7 was isolated using two-step HPLC (first pass, SAX using a 0 50% Compound 7 was dissolved in 1 mL of a 1:1 mixture of t-BuOH and H2O. To this solution was added distilled morpholine (10 µL, 0.114 mmol), and the reaction mixture was stirred at rt for 10 min, then set to reflux. A solution of DCC (25 mg, 0.114 mmol) in 0.5 mL of tBuOH was added over a period of 1.5 h, and the reaction mixture was then refluxed for 5 h.
Volatiles were removed under reduced pressure, the residue taken up in water, and the resulting suspension filtered. The aqueous solution was extracted twice with ether, and then re-evaporated under reduced pressure. The resulting residue (8) was dried using the oil pump and used in the next step without further purification.
A solution of tetrasodium pyrophosphate (30 mg, 0.114 mmol) in 1 mL water was passed through DOWEX H + . The solvent was removed and the residue dissolved in 1 mL 50% aqueous ethanol. Tributylamine (34 µL, 0.171 mmol, 1.5 eq) was added and the S10 resulting solution stirred at rt for 1 h. The solvent was removed, and the residue was coevaporated with ethanol, and the resulting glassy solid was dried using an oil pump. The product was dissolved in 1 mL of dry DMSO.
The solution of tributylammonium pyrophosphate in DMSO was added dropwise to a solution of morpholidate 8 in 1 mL dry DMSO dropwise. The reaction was stirred for 24 h at rt. The product 1 was isolated using two-step preparative HPLC: first pass, SAX ion exchange column, 0 100% linear gradient, A = water, B = 0.5 M TEAB, pH = 7.5, 25 min, 8 mL/min; second pass, RP HPLC on a C-18 preparative column using 0.1 M TEAB, 5% CH3CN, pH = 7, 8 mL/min under isocratic conditions. The fractions containing 1 were combined and lyophilized, giving the product as a white crystalline solid (4.1 mg, 25% over three 
III. SAMHD1 cloning and overexpression.
Full-length SAMHD1 (1881 bp) was expressed as a N-terminal His10-PPS fusion in
Escherichia coli BL21-DE3 cells (Novagen) as previously described 6 . Protein concentration was determined by absorbance measurements at 280 nm using the calculated (Protparam S11 tool, ExPASy) molar extinction coefficients for full-length human SAMHD1 monomer (ε = 76,500 M -1 cm -1 ). Protein yields were typically 20 mg/L of bacterial culture. Purified protein was stored at -80°C in small portions. Experiments were initiated by thawing a single (20 μL) aliquot, which was stored at -20°C, and then used over the course of three days before being discarded.
IV. Mass spectrometry analysis of H 2 18 O incorporation into product.
Mass spectrometry was performed on a TSQ Vantage TripleStage Quadrupole mass spectrometer (Thermo Fisher Scientific). Instrument settings were optimized in negative ion mode for dG and PPPi by infusing standard solutions. The SAMHD1 enzymatic reactions were carried out at 22°C with 2 μM SAMHD1 and 1 mM dGTP in a buffer consisting of 50 mM ammonium acetate (pH 7.5), 50 mM KCl, and 5 mM MgCl2 in either standard ddH2O or globally fitting the entire data set to a competitive inhibition model (eq 1).
(1)
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Inhibition by 1 at the A2 or catalytic sites of SAMHD1. Distinguishing between competitive binding by 1 at either the A2 or catalytic sites was achieved by addition of 1 before or after A1 site activator (GTP). Competitive binding by 1 at the catalytic site was examined by pre-assembling a reaction mixture containing SAMHD1 (0.5 μM), GTP (5 mM) activator and dUTP (1 mM) substrate, which were allowed to proceed for 2.5 minutes. At this time, varying concentrations of 1 (0.5 to 4 mM) were added to the reaction mixture and dUTP substrate hydrolysis was monitored over time. Alternatively, inhibition caused by binding of 1 to the A2 activator site was probed by pre-incubation of SAMHD1 (0.5 μM), GTP (5 mM) activator and varying concentrations of 1 (50 μM to 2 mM) prior to initiation with dUTP (1 mM) substrate. In both cases, the inhibited reaction rates (μM/s) were normalized to rates obtained in the absence of inhibitor and plotted versus concentration of 1 (eq 2,3). The data was fitted using nonlinear least squares optimization to obtain true inhibition constants (Ki) for the A2 and catalytic binding sites.
Dilution-jump kinetic measurements.
In the standard assay SAMHD1 (10 µM) was incubated for 15 seconds with varying concentrations of GTP (0.5 mM), dUTP(1 mM), and/or 1 (5 mM) prior to a 100-fold dilution into standard reaction buffer containing [5-
3 H] dUTP (1 mM). Time points were then quenched on a TLC plate and product formation was quantified as described above. Plots of [dU] against time were fitted to the equation Alternatively, GTP (5 mM) and 1 (0.05 -1 mM) were pre-incubated (5 min) with SAMHD1 (0.5 µM)
prior to initiation with [5-3 H] dUTP (1 mM) substrate. Substrate hydrolysis was evaluated using the C18-RP TLC kinetic assay. 0  10  20  30  40  50  60  70  80  90  100  110  120  130  140  150  160  170  180 f1 (ppm)
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